Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,064	1,010	956.4	957.49	750.74	607.51
Other Revenue	22.81	-	-	-	-	-
Revenue	1,087	1,010	956.4	957.49	750.74	607.51
Revenue Growth (YoY)	7.09%	5.58%	-0.11%	27.54%	23.58%	8.78%
Cost of Revenue	452.87	391.87	346.53	409.83	293.18	224.99
Gross Profit	633.68	617.86	609.88	547.65	457.57	382.53
Selling, General & Admin	60.95	58.52	54.99	48.88	41.01	39.78
Other Operating Expenses	368.66	364.24	326.71	316.7	254.01	182.61
Operating Expenses	466.56	459.23	416.06	397.91	327.83	250.59
Operating Income	167.12	158.64	193.81	149.74	129.74	131.94
Interest Expense	-0.23	-	-	-0.02	-3.77	-6.03
Interest & Investment Income	10.81	10.81	2.32	0.72	1.84	1.32
Other Non Operating Income (Expenses)	-0.82	-0.82	-1.07	-1.31	-0.78	0.17
EBT Excluding Unusual Items	176.88	168.62	195.07	149.13	127.03	127.39
Gain (Loss) on Sale of Investments	10.61	10.61	0.02	-	-	-
Gain (Loss) on Sale of Assets	-	-	0.08	1.43	-	0
Other Unusual Items	-	-	-	-	-	19.86
Pretax Income	187.49	179.23	195.17	150.79	127.03	147.26
Income Tax Expense	48.43	45.65	50.16	37.45	34.9	31.15
Net Income	139.06	133.58	145.01	113.34	92.13	116.11
Net Income to Common	139.06	133.58	145.01	113.34	92.13	116.11
Net Income Growth	-9.86%	-7.88%	27.94%	23.02%	-20.65%	143.68%
Shares Outstanding (Basic)	12	12	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12	12	12
Shares Change (YoY)	-0.05%	-	-	-	-	-
EPS (Basic)	11.31	10.86	11.78	9.21	7.49	9.44
EPS (Diluted)	11.31	10.86	11.78	9.21	7.49	9.44
EPS Growth	-9.77%	-7.84%	27.90%	23.00%	-20.64%	143.64%
Free Cash Flow	-	149.34	141.69	57.43	44.13	70.36
Free Cash Flow Per Share	-	12.14	11.52	4.67	3.59	5.72
Dividend Per Share	-	-	-	-	1.250	-
Gross Margin	58.32%	61.19%	63.77%	57.20%	60.95%	62.97%
Operating Margin	15.38%	15.71%	20.27%	15.64%	17.28%	21.72%
Profit Margin	12.80%	13.23%	15.16%	11.84%	12.27%	19.11%
Free Cash Flow Margin	-	14.79%	14.81%	6.00%	5.88%	11.58%
EBITDA	205.16	195.1	228.17	182.07	162.55	160.13
EBITDA Margin	18.88%	19.32%	23.86%	19.02%	21.65%	26.36%
D&A For EBITDA	38.04	36.47	34.36	32.33	32.81	28.19
EBIT	167.12	158.64	193.81	149.74	129.74	131.94
EBIT Margin	15.38%	15.71%	20.27%	15.64%	17.28%	21.72%
Effective Tax Rate	25.83%	25.47%	25.70%	24.84%	27.47%	21.15%
Revenue as Reported	1,108	1,031	958.83	959.87	752.58	609.41

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.